Liyang, China,, April 19, 2025 / Prnewswire / – On April 19, 2025The Blood Purification Professional Committee (BPPC) of China Medical Association (CMDIA) gathered in Liuyang, HunanFor its annual conference, “synergy and endless innovation” on the theme. This pivotal event has united regulations leaders, university experts and pioneering medical devices to propel the progress of blood purification technologies, an integral part of the treatment of kidney disease, poisoning, multi-body failure and immune disorders.
With more than 120 million people with chronic kidney disease, and more than a million requiring dialysis, affordable and accessible treatment is urgent. Historically dependent on expensive imported technologies, China The transition to domestic innovation marks a transformer era under the leadership of BPPC. “Our mission is to connect cutting -edge technology to patient needs,” said Professor Wang Niansinsus, president of the committee and head of nephrology at Shanghai Sixth People hospital. The conference highlighted collaboration efforts between universities, industry and regulators that improve blood purification systems, including the progress of blood purification technologies, intelligent monitoring systems and integrated care platforms.
Companies love Chongqing Sws Medical is at the forefront of this movement, illustrating innovation and contributing considerably to national standards. Tong Jin, director of the Swes Medical’s Technology Center, shared the company’s decade trip, highlighting the breakthroughs in dialysis machines and continuous renal replacement therapy equipment (CRRT). “Our achievements, recognized through national programs and key patents, show that Chinese companies can lead to complex medical fields,” he said, reflecting the wider thrust of self-innovation and excellence.
The conference explored innovations, including precision medicine with a purification of targeted plasma and optimized AI parameters, as well as breakthroughs such as ultra-pure dialysis via the central concentrate delivery system and the management of intelligent IoT peritoneal dialysis. The progress of treatments for kidney diseases, in particular immunoglobulin has nephropathy and emerging technologies such as sequencing genes and stem cells, report a change towards proactive health management. These multidisciplinary and early intervention efforts have significant global potential.
The conference focused on the integration of artificial intelligence to develop hemodialysis ecosystems “Smart hemodialysis, with companies like Sws Medical leading this change through their model” Device + System + Service “which synergies medical aircraft, data analysis and remote services to stimulate efficiency and extend accessibility, in particular in sub-services areas. The recording of domestic medical devices reaching 67.01% and more than 90% of the bloody infusion devices now located, China Progress is firmly supported by solid government initiatives and market -oriented innovation, guaranteeing membership of strict clinical and regulatory standards.
Chinese companies now export affordable and high -quality solutions that question the western markets while aligning the “Healthy China 2030” strategy and the objectives of the World Health Organization for the Chronic Renal Disease of the World Health Organization. As China Approach to the conclusion of its 14th five -year plan, this conference means a pivotal moment, with leadership and committee companies as SWS Medical heading a transformation to intelligent technologies, centered on the patient and competitive on a global scale.
For patients, this results in better access to vital treatments, while for the global medical community, it underlines China The emergence as a leader in health care innovation. As Professor Wang said with eloquence: “The spark of inflamed innovation here will transform lives far beyond China Borders. “”
Show the original content:https://www.prnewswire.com/apac/news-releases/innovation-and-collaboration-dvancing-chinasblood-purification-industry-302432591.html
Source Sws Medical
